Therapix Biosciences (TRPX) Reports First Patient Enrollment for Clinical Trial at Assuta Medical Center for Treating Obstructive Sleep Apnea
Tweet Send to a Friend
Therapix Biosciences Ltd. (NASDAQ: TRPX) announced that on June 05, 2018, the first subject was enrolled for its Phase IIa ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
